Infectious diseases

Infectious diseases are caused by pathogenic microorganisms such as bacteria, viruses, parasites and fungi. The implementation of next-generation sequencing (NGS) in healthcare will enable fast and reliable identification of these microorganisms, which will in turn increase the possibility of mapping the spread of infectious diseases and detecting antibiotic resistance.

Male doctor talking to man in hospital environment.

In Sweden, 65,000 patients are diagnosed annually with care-related infections and approximately 1,500 die as a result of an infectious disease. It is believed that nearly half of these deaths could be prevented through earlier detection and treatment.

NGS improves clinical diagnostics

Methods in which whole or parts of microbial genomes (genetic material) are examined with the use of NGS have significant potential for clinical diagnostics and treatment of infectious diseases. With the help of these techniques, certain microorganisms can be correctly identified, and antibiotic resistance can be determined, within a much shorter space of time. With NGS the fastest analyses take just a few hours. Currently, the most successful use of NGS is on cultivated bacteria, however the goal is to find refined solutions in the foreseeable future, which may identify a pathogen directly from the patient’s sample (such as a blood test) in order to speed up diagnostics. This is especially important in cases of serious infection, such as sepsis and meningitis.

Technology development makes it possible to reduce the spread of infectious diseases

By implementing NGS in healthcare, we can reduce the risk of infectious diseases spreading and thereby the occurrence of care related infections that often involve the problem of resistance. This will require new technical solutions, an IT structure for data storage and data processing at hospitals, and the construction of a national database where methods and results can easily be shared between regions that have been affected by an outbreak of infection, and where the source of infection needs to be mapped out with the use of one single method. In the long run it might also be possible to make international comparisons.

Microbiology and infectious diseases are a focus for GMS

Our goal is to achieve fast and reliable identification of microorganisms that cause infectious diseases. Quality assured methods and results should be easily shared between regions in Sweden with the use of national technical solutions. This is necessary in order to, for example, identify pathways of infection in the case of outbreaks and achieve a national consensus on the characterisation of pathogenic microorganisms. Genomic Medicine Sweden will therefore be developing common guidelines for the next-generation sequencing of a number of pathogens as well as contributing to the development of improved methods of analysis for microbial whole genome samples from cultivated bacteria.

Introduction disease areas

Genomic Medicine Sweden (GMS) focuses primarily on disease areas where there is currently definite evidence that suggests that genetic analyses can be used to diagnose disease, or where genetic deviations are important to prognostic assessment, choice of treatment and follow-up. We work primarily with rare diseases, solid tumours, hematological malignancies, infectious diseases and pharmacogenomics. GMS also has a particular focus on childhood cancer.